Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

274
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
274
Cancer Survival Analysis01:21

Cancer Survival Analysis

456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

292
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
292
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

178
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
178
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

540
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
540
Documentation of Nursing Diagnosis01:10

Documentation of Nursing Diagnosis

1.3K
The nurse documents nursing diagnoses and enters them into the patient record. The identified patient's nursing diagnosis is either written out with a plan of care or entered into the electronic health record.
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...
1.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Assessing social media platform data access for automated early warning of public health threats.

European journal of public health·2026
Same author

Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network.

Journal of gynecologic oncology·2026
Same author

ASO Visual Abstract: Association Between Axillary Surgical Management and Survival in Patients with de novo Metastatic Breast Cancer.

Annals of surgical oncology·2026
Same author

First steps in establishing surveillance of bloodstream infections from electronic health record derived data, EU/EEA countries, March 2023 to March 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Acquired Willebrand syndrome during continuous or pulsatile extracorporeal carbon dioxide removal.

American journal of respiratory and critical care medicine·2026
Same author

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026

相关实验视频

Updated: Sep 16, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

评估乳腺癌查表现,没有使用注册表,使用医疗行政数据.

Emilien Jemelen1,2, Francisco Orchard3, William Madie3

  • 1French Institute for Research in Computer Science and Automation (INRIA), Paris, France. emilien.jemelen@inria.fr.

Scientific reports
|July 11, 2025
PubMed
概括

这项研究使用卫生行政数据评估了法国乳腺癌查绩效,发现每1000次检查中癌症检测率为10.9. 这种方法为评估查有效性提供了一个可行的替代方案,在没有癌症登记册的情况下.

关键词:
癌症登记处 癌症登记处数据链接数据链接欧洲卫生政策 欧洲卫生政策全场数码乳房扫描 (FFDM) 是一种全场数码乳房扫描.间隔癌症发生率 间隔癌症发生率有组织的乳腺癌查.绩效评估是指进行绩效评估.国家卫生数据系统 (SNDS) 的行政数据.

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

380

相关实验视频

Last Updated: Sep 16, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

380

科学领域:

  • 在瘤学瘤学.
  • 公共卫生 公共卫生
  • 医疗信息学 医疗信息学

背景情况:

  • 法国乳腺癌查计划 (DOCS) 的目标是早期发现乳腺癌 (BC).
  • 关键绩效指标 (KPI),如敏感度和癌症检测率 (CDR),对于评估查计划至关重要.
  • 在法国,访问BC注册表以链接查数据是有限的,这阻碍了性能指标的计算.

研究的目的:

  • 评估使用医疗行政数据的可行性和有效性,特别是法国国家健康数据系统 (SNDS),以计算BC查绩效指标.
  • 建立一个替代方法来评估在缺乏可访问的癌症登记册的地区的查计划.

主要方法:

  • 与法国国家健康数据系统 (SNDS) 连接区域数字乳房扫描查数据 (2011-2020年).
  • 在查后24个月跟踪女性,以确定查检测和间隔癌症.
  • 计算的关键绩效指标:灵敏度 (SE),正预测值 (PPV),癌症检测率 (CDR) 和间隔癌症率 (ICR).

主要成果:

  • 分析了来自女性的252,786份查检查,平均年龄为61岁.
  • 获得了77.9%的灵敏度 (SE) 和19.8%的积极预测值 (PPV).
  • 报告的癌症检测率 (CDR) 为每1000次检查中10.9%,间隔癌症率 (ICR) 为每1000次检查中2.4%.

结论:

  • 医疗行政数据 (SNDS) 为计算法国乳腺癌查绩效指标提供了一种可重复的方法.
  • 这种方法在癌症登记有限或无法访问的地区是有价值的替代方案.
  • 建议在注册表覆盖的地区进行进一步的验证,以确认该方法的更广泛的适用性.